These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 201575)

  • 21. Cell-mediated immunity against particulate and solubilized tumor-associated antigens of murine plasmacytomas detected by macrophage migration inhibition assays.
    Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
    Int J Cancer; 1977 Oct; 20(4):624-31. PubMed ID: 914399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface proteins of simian-virus-40-transformed cells.
    Chandrasekaran K; Winterbourne DJ; Luborsky SW; Mora PT
    Int J Cancer; 1981 Mar; 27(3):397-407. PubMed ID: 6169662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.
    Glaser M
    J Natl Cancer Inst; 1978 Nov; 61(5):1351-5. PubMed ID: 213615
    [No Abstract]   [Full Text] [Related]  

  • 24. Local adoptive transfer of antitumor cellular immunity to xenogeneic animals studied with a rapid radioisotopic footpad assay.
    Takeichi N; Economou GC; Boone CW
    J Natl Cancer Inst; 1976 Jul; 57(1):131-4. PubMed ID: 1003496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction and inhibition of host immunity to experimental neoplasms. Discussion.
    Br J Cancer Suppl; 1973 Aug; 1():62-71. PubMed ID: 4804291
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.
    Chapes SK; Gooding LR
    J Immunol; 1985 Sep; 135(3):2192-8. PubMed ID: 2991384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity of cell membrane antigens in prostatic cancer.
    Brannen GE; Gomolka DM; Coffey DS
    Cancer Chemother Rep; 1975; 59(1):127-38. PubMed ID: 1131799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.
    Schirrmacher V
    Int J Cancer; 1979 Jul; 24(1):80-6. PubMed ID: 314423
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro induction of tumor-specific immunity by highly purified VSV grown in SV40-transformed cells and tumor glycolipids incorporated into liposomes.
    Ansel S
    Int J Cancer; 1983 Jun; 31(6):785-90. PubMed ID: 6190766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed hypersensitivity to simian virus 40 tumor cells in BALB-c mice demonstrated by a radioisotopic foot-pad assay.
    Paranjpe MS; Boone CW
    J Natl Cancer Inst; 1972 Feb; 48(2):563-6. PubMed ID: 4347042
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor.
    Howell SB; Dean JH; Law LW
    Int J Cancer; 1975 Jan; 15(1):152-69. PubMed ID: 236258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.
    Faas SJ; Pan S; Pinkert CA; Brinster RL; Knowles BB
    J Exp Med; 1987 Feb; 165(2):417-27. PubMed ID: 3029269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discussion paper: specific paralysis of the antitumor cellular immune response produced by growing tumors studied with a radioisotope footpad assay.
    Paranjpe MS; Boone CW; Takeichi N
    Ann N Y Acad Sci; 1976; 276():254-9. PubMed ID: 194516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of fetal antigens in tumor cells.
    Ting CC; Lavrin DH; Shiu G; Herberman RB
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1664-8. PubMed ID: 4340152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies.
    Kennedy RC; Dreesman GR; Butel JS; Lanford RE
    J Exp Med; 1985 Jun; 161(6):1432-49. PubMed ID: 2409201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-specific transplantation antigen is expressed during SV40 lytic infection with wild-type and tsA mutant viruses.
    Anderson JL; Martin RG; Chang C; Mora PT
    Virology; 1977 Jan; 76(1):254-62. PubMed ID: 189492
    [No Abstract]   [Full Text] [Related]  

  • 38. Tumor-specific transplantation antigen: use of the Ad2+ND1 hybrid virus to identify the protein responsible for simian virus 40 tumor rejection and its genetic origin.
    Jay G; Jay FT; Chang C; Friedman RM; Levine AS
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3055-9. PubMed ID: 80009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of the anti-tumor delayed hypersensitivity response in mice with progressively growing tumors: stimulation followed by specific suppression.
    Paranjpe MS; Boone CW
    Int J Cancer; 1974 Feb; 13(2):179-86. PubMed ID: 4361649
    [No Abstract]   [Full Text] [Related]  

  • 40. Preparation of membrane fractions with enhanced tumor-transplantation-antigen activity from tumor cells infected with influenza virus.
    Boone CW; Orme TW; Blackman K; Gillette R
    J Natl Cancer Inst; 1973 Oct; 51(4):1141-4. PubMed ID: 4355600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.